NCT01820234

Brief Summary

The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following:

  1. 1.Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance.
  2. 2.Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance.
  3. 3.The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2011

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
1.8 years until next milestone

First Posted

Study publicly available on registry

March 28, 2013

Completed
Last Updated

July 19, 2017

Status Verified

March 1, 2013

Enrollment Period

9 months

First QC Date

February 4, 2011

Last Update Submit

July 17, 2017

Conditions

Keywords

Skin cancerTeledermatologyScreeningStore-and-forward

Outcome Measures

Primary Outcomes (1)

  • Aggregated diagnostic concordance

    Aggregated diagnostic concordance which is defined as the agreement of the in-person dermatologist's principle diagnosis with the teledermatologist's primary diagnosis or any of the differential diagnoses.

    At the time of dermatologist evaluation (Day 1)

Secondary Outcomes (5)

  • Primary diagnostic concordance

    At the time of dermatologist evaluation (Day 1)

  • Categorical diagnostic concordance

    At the time of dermatologist evaluation (Day 1)

  • Management concordance

    At the time of dermatologist evaluation (Day 1)

  • Sensitivity

    At the time of dermatologist evaluation (Day 1)

  • Specificity

    At the time of dermatologist evaluation (Day 1)

Study Arms (2)

In-person dermatology evaluation

OTHER

Health care modality

Other: In-person dermatology evaluation

Store-and-forward teledermatology evaluation

OTHER

Health care modality

Other: Store-and-forward teledermatology evaluation

Interventions

Every patient will be evaluated by an in person dermatologist present at the screening.

In-person dermatology evaluation

Every patient will be evaluated online via a store and forward teledermatology modality.

Also known as: Health care modality
Store-and-forward teledermatology evaluation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older at time of consent, may be male or female.
  • Able to provide a brief medical history and have/allow an examination of their skin including photographs.
  • Capable of giving informed consent.
  • Will be able to receive notification of follow-up recommendations

You may not qualify if:

  • Patients who will not provide informed consent
  • Patient who are unable to fulfill tasks of this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Davis Shifa Community Clinic

Sacramento, California, 95818, United States

Location

MeSH Terms

Conditions

Skin Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • April W Armstrong, MD, MPH

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2011

First Posted

March 28, 2013

Study Start

September 1, 2010

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

July 19, 2017

Record last verified: 2013-03

Locations